Seethalakshmi L, Flores C, Diamond D A, Menon M
Division of Urologic Transplantation and Surgery, University of Massachusetts Medical Center, Worcester 01655.
J Urol. 1990 Dec;144(6):1489-92. doi: 10.1016/s0022-5347(17)39783-5.
We have shown earlier that the administration of cyclosporine impairs testicular function and causes a decrease in sperm counts, sperm motility and fertility. In order to determine whether or not the deleterious effects of CsA could be reversed by hormonal therapy, we injected sexually mature male Sprague Dawley rats with cremaphor + saline or CsA (40 mg./kg./d) alone or in combination with human chorionic gonadotropin (hCG; five micrograms./d/rat) and follicle stimulating hormone (FSH; five micrograms./d/rat). The injections were given subcutaneously for 14 days. As expected, CsA administration decreased the body and reproductive organ weights, testicular and epididymal sperm counts, sperm motility and fertilizing ability. Serum levels of LH were elevated and testosterone was decreased. The administration of FSH + hCG to the CsA treated rats restored the body and reproductive organ weights, sperm counts and motility. Seventy five percent of gonadotropin treated males were fertile as compared to 25% in the CsA treated group. In the hormone treated group, the blood levels of CsA were 50% of that of CsA treated group. In order to verify whether or not the decline in the blood levels of CsA was the cause for the amelioration of CsA-induced changes in the reproductive function, we compared the CsA + hormone treated group with another group treated with five mg./kg./d CsA which had blood levels of CsA comparable to the former group. In the five mg./kg./d group the reproductive functions were significantly lower than the CsA + hormone treated group suggesting, therefore, that the restoration of reproductive functions in the CsA + hormone treated group is a result of hormonal treatment. Administration of CsA (40 mg./kg./d) reduced the kidney weight and increased the levels of serum creatinine: these changes were also ameliorated by the administration of hCG + FSH.
我们之前已经表明,给予环孢素会损害睾丸功能,并导致精子数量、精子活力和生育能力下降。为了确定激素疗法是否能逆转环孢素A(CsA)的有害作用,我们给性成熟的雄性斯普拉格-道利大鼠皮下注射聚氧乙烯蓖麻油+生理盐水或单独的CsA(40毫克/千克/天),或与人类绒毛膜促性腺激素(hCG;5微克/天/只大鼠)和促卵泡激素(FSH;5微克/天/只大鼠)联合注射,持续14天。正如预期的那样,给予CsA会降低体重和生殖器官重量、睾丸和附睾中的精子数量、精子活力以及受精能力。血清促黄体生成素(LH)水平升高,睾酮水平降低。给接受CsA治疗的大鼠注射FSH + hCG可恢复体重和生殖器官重量、精子数量和活力。接受促性腺激素治疗的雄性大鼠中有75%具有生育能力,而在CsA治疗组中这一比例为25%。在激素治疗组中,CsA的血药浓度是CsA治疗组的50%。为了验证CsA血药浓度下降是否是CsA诱导的生殖功能变化得到改善的原因,我们将CsA + 激素治疗组与另一组接受5毫克/千克/天CsA治疗且血药浓度与前一组相当的大鼠进行了比较。在5毫克/千克/天组中,生殖功能明显低于CsA + 激素治疗组,因此表明CsA + 激素治疗组生殖功能的恢复是激素治疗的结果。给予CsA(40毫克/千克/天)会降低肾脏重量并提高血清肌酐水平:给予hCG + FSH也可改善这些变化。